InvestSMART

Vitasora Health Limited (ASX: VHL) - Share Price

- Current share price for VHL : $0.011

Vitasora Health Limited (VHL, formerly Respiri Limited) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is an international e-Health SaaS company supporting respiratory health management focusing primarily on supporting the US remote patient monitoring market. Its technology detects wheeze, a typical symptom of Asthma, COPD and respiratory disease to provide an objective measure of airway limitation. Vitasora Health created technology optimises how patients in partnership with their physicians manage chronic respiratory conditions.

VHL General Information +

ASX Code VHL
Website N/A
Industry/Sector Health Care Equipment
Market Cap ($M) 25
VHL Share Price $0.011
Day High $0.011
Day Low $0.011
Last Close $0.011
VHL Share Price Movement - ( No change )
Prices as at 16:40, 20 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Vitasora Health Limited (VHL) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Vitasora Health Limited (VHL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Vitasora Health Limited (VHL) price-sensitive announcements

VHL - VHL CCM Patients Outperform Benchmarks, Enhancing Growth
Vitasora Health Limited (ASX: VHL) announced that patients in its US Chronic Care Manageme
Vitasora Health Limited (VHL)
9 Nov 2026 | 8:20 AM
VHL - Quarterly Activities/Appendix 4C Cash Flow Report
Vitasora Health Limited’s Quarterly Activities Report and Appendix 4C for the quarter ende
Vitasora Health Limited (VHL)
30 Oct 2026 | 9:15 AM
VHL - VHL Secures Major Contract and $3m Working Capital Facility
Vitasora Health Limited (ASX: VHL) announced that it has secured a major new US healthcare
Vitasora Health Limited (VHL)
30 Oct 2026 | 9:13 AM
VHL - Notice of Annual General Meeting/Proxy Form
Vitasora Health Limited’s Notice of Annual General Meeting and Proxy Form announces that t
Vitasora Health Limited (VHL)
29 Oct 2026 | 4:01 PM

Vitasora Health Limited (VHL) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
Health Care $26 VHL CCM Patients Outperform Benchmarks, Enhancing Growth 9 Nov 2026 8:20AM $0.011 $0.011 fallen by 0%
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
Health Care $26 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2026 9:15AM $0.013 $0.011 fallen by 15.38%
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
Health Care $26 VHL Secures Major Contract and $3m Working Capital Facility 30 Oct 2026 9:13AM $0.013 $0.011 fallen by 15.38%
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
Health Care $26 Consolidation/Split - VHL 29 Oct 2026 4:02PM $0.013 $0.011 fallen by 15.38%
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
Health Care $26 Notice of Annual General Meeting/Proxy Form 29 Oct 2026 4:01PM $0.013 $0.011 fallen by 15.38%
Vitasora Health Limited (VHL)
ORDINARY FULLY PAID
Health Care $26 Breach of Listing Rule 7.1 7 Oct 2026 1:56PM $0.012 $0.011 fallen by 8.33%

VHL Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$10.61 -$0.60 -19.40% 0.00 0.00 0.00% 0.0%
2025A -$10.11 -$0.70 -1.40% 0.00 0.00 0.00% 0.0%
2024A -$7.44 -$0.70 1.40% 0.00 0.00 0.00% 0.0%

VHL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
Cochlear Limited (COH) $10,063M -0.3136 0.2540 0.0785 37.4607 29.8730 27.6989 2.24% 2.33% 2.53%
Fisher & Paykel Healthcare Corporation Limited (FPH) $23,889M 0.1388 0.1474 0.1575 61.4093 53.5187 46.2370 1.07% 1.16% 1.29%
Imricor Medical Systems Inc (IMR) $470M -0.4254 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ResMed Inc. (RMD) $20,370M 9.5922 0.1126 0.0881 23.6413 21.2489 19.5280 0.98% 1.04% 1.12%
Vitasora Health Limited (VHL) $26M -0.1944 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

VHL Directors

Name Position Start Date
Mr Nicholas Smedley Executive Chairman, Executive Director 30 Oct 2019
Mr Marjan Mikel Executive Director, Chief Executive Officer, Managing Director 25 Nov 2019
Mr Jonathan Adams Non-Executive Director 24 Feb 2025

Vitasora Health Limited (VHL) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
1 Oct 2025 MIKEL, Marjan Issued Direct Shares 1,333,333 $0.030 $39,999.990
1 Oct 2025 MIKEL, Marjan Issued Indirect Shares 2,000,000 $0.030 $60,000.000
1 Oct 2025 SMEDLEY, Nicholas Issued Indirect Shares 3,333,333 $0.030 $99,999.990

See all changes in directors' interest & trades for Vitasora Health Limited (VHL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

VHL Management

Name Position
Tony Di Pietro Company Secretary
Peter Hildebrandt COO
Samaneh Sarraf Shirazi Other Corporate Officer

VHL Calendar of Events

Date Event
27 August 2027 Report (Annual)
27 August 2027 Report (Prelim)
26 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.